Skip to content
Screener

Ovid Therapeutics OVID Q2 2025 earnings

Reported August 13, 2025 · Before market open

Revenue$6.3MBeat by $6.2M
EPS-$0.06Beat by $0.10
Revenue estimate$61.3K
EPS estimate-$0.16

Next report

Nov 11, 2026 (In 1 week)
Revenue estimate$31.1K
EPS estimate-$0.08

FAQ

When did Ovid Therapeutics report Q2 2025 earnings?
Ovid Therapeutics (OVID) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Ovid Therapeutics's Q2 2025 revenue and EPS?
Ovid Therapeutics reported revenue of $6.3M and eps of $-0.06 for Q2 2025.
Did Ovid Therapeutics beat estimates in Q2 2025?
Revenue beat the consensus estimate of $61.3K by $6.2M. EPS beat the consensus estimate of $-0.16 by $0.10.
How did Ovid Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3611.2% from $169.0K a year earlier.
Where can I find Ovid Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-040007) and the 10-Q periodic report (0001628280-25-040008) directly on SEC EDGAR. The filing index links above go to sec.gov.